Genomma Lab Internacional. de Salute del bilancio
Salute finanziaria criteri di controllo 5/6
Genomma Lab Internacional. de ha un patrimonio netto totale di MX$11.2B e un debito totale di MX$6.6B, che porta il suo rapporto debito/patrimonio netto a 59.1%. Le sue attività totali e le sue passività totali sono rispettivamente MX$23.5B e MX$12.4B. L'EBIT di Genomma Lab Internacional. de è MX$3.7B rendendo il suo rapporto di copertura degli interessi 4.2. Ha liquidità e investimenti a breve termine pari a MX$1.8B.
Informazioni chiave
59.1%
Rapporto debito/patrimonio netto
Mex$6.59b
Debito
| Indice di copertura degli interessi | 4.2x |
| Contanti | Mex$1.83b |
| Patrimonio netto | Mex$11.15b |
| Totale passività | Mex$12.36b |
| Totale attività | Mex$23.51b |
Aggiornamenti recenti sulla salute finanziaria
Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet
Oct 17
These 4 Measures Indicate That Genomma Lab Internacional. de (BMV:LABB) Is Using Debt Reasonably Well
May 31Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly
Jan 29Is Genomma Lab Internacional. de (BMV:LABB) Using Too Much Debt?
Mar 31Does Genomma Lab Internacional. de (BMV:LABB) Have A Healthy Balance Sheet?
Dec 07Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet
Jul 27Recent updates
Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet
Oct 17Calculating The Intrinsic Value Of Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB)
Sep 11With Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) It Looks Like You'll Get What You Pay For
Jul 12These 4 Measures Indicate That Genomma Lab Internacional. de (BMV:LABB) Is Using Debt Reasonably Well
May 31Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly
Jan 29Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 49% Discount?
Nov 07Is Genomma Lab Internacional. de (BMV:LABB) Using Too Much Debt?
Mar 31Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 32% Discount?
Feb 24Does Genomma Lab Internacional. de (BMV:LABB) Have A Healthy Balance Sheet?
Dec 07Rainbows and Unicorns: Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Analysts Just Became A Lot More Optimistic
Sep 24Analysts Just Made A Major Revision To Their Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Revenue Forecasts
Aug 01Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet
Jul 27Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly
Mar 22Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 44%?
Feb 15Genomma Lab Internacional. de (BMV:LABB) Seems To Use Debt Quite Sensibly
Nov 24Here's Why I Think Genomma Lab Internacional. de (BMV:LABB) Is An Interesting Stock
Sep 08Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Intrinsic Value Is Potentially 96% Above Its Share Price
Jun 10Is Genomma Lab Internacional. de (BMV:LABB) A Risky Investment?
May 24Should You Be Adding Genomma Lab Internacional. de (BMV:LABB) To Your Watchlist Today?
May 06Investors Who Bought Genomma Lab Internacional. de (BMV:LABB) Shares Five Years Ago Are Now Up 65%
Mar 13Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet
Feb 19Do Its Financials Have Any Role To Play In Driving Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Stock Up Recently?
Feb 02Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 42%?
Jan 15What Is The Ownership Structure Like For Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB)?
Dec 28Genomma Lab Internacional. de (BMV:LABB) Shareholders Have Enjoyed A 54% Share Price Gain
Dec 10
Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( MX$12.2B ) di LAB B superano le sue passività a breve termine ( MX$6.7B ).
Passività a lungo termine: Le attività a breve termine di LAB B ( MX$12.2B ) superano le sue passività a lungo termine ( MX$5.6B ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: Il rapporto debito netto/patrimonio netto ( 42.7% ) di LAB B è considerato alto.
Riduzione del debito: Il rapporto debito/patrimonio netto di LAB B si è ridotto da 74.3% a 59.1% negli ultimi 5 anni.
Copertura del debito: Il debito di LAB B è ben coperto dal flusso di cassa operativo ( 39% ).
Copertura degli interessi: I pagamenti degli interessi sul debito di LAB B sono ben coperti dall'EBIT ( 4.2 x copertura).